|
<<
Page 2 of 3 >>
Global pharmaceutical market growth accelerates to 11%
in 1999
Leading Therapy Classes
The
top ten therapy classes accounted for nearly 30% of the
total world market in 1999. Four out of the leading ten
- Cholesterol & Triglyceride Reducers, Antirheumatic Non-Steroidals,
Antipsychotics and Oral Antidiabetics - are growing at
20% or more, year-over-year.
|
Leading
therapy classes in 1999 global pharmaceutical sales
|
|
Rank
|
Therapy
Class
|
1999
Sales US$Bn
|
%
Global Sales
|
%
Growth Year-on-Year*
|
| 1
|
Antiulcerants
|
15.8
|
5.3%
|
12%
|
| 2
|
Cholest
& Triglyceride Reducers |
13.4
|
4.5%
|
21%
|
| 3
|
Antidepressants
|
11.7
|
4.0%
|
17%
|
| 4
|
Calcium
Antagonists Plain |
9.9
|
3.3%
|
4%
|
| 5
|
Antirheumatic
Non-Steroidals |
7.7
|
2.6%
|
23%
|
| 6
|
ACE
Inhibitors Plain |
7.4
|
2.5%
|
5%
|
|
7 |
Cephalosporins
& Combinations |
7.3
|
2.5%
|
4%
|
| 8
|
Non-Narcotic
Analgesics |
6.2
|
2.1%
|
1%
|
| 9
|
Antipsychotics
|
5.1
|
1.7%
|
26%
|
| 10
|
Oral
Antidiabetics |
4.8
|
1.6%
|
22%
|
| 11 |
|
|
|
|
|
Leading
10 ATCs at Level 3 |
89.3
|
30.2%
|
13%
|
Source:
IMS HEALTH World
Review 2000 (*Growth measured in Local Currency Dollars)
The Antiulcerant class was valued at $15.8
billion in 1999, and remains the leading therapeutic class
worldwide, as it has for the past nine years. Representing
5.3% of all audited global pharmaceutical sales, antiulcerant
sales were up 12% year-on-year. AstraZeneca's Losec/Prilosec
(omeprazole), the world's leading antiulcerant product
and number one selling drug, accounts for $5.7 billion,
or over 36%, of all sales in this class.
The Cholesterol
& Triglyceride Reducers class grew a very strong 21%,
placing it second in sales rankings. Antidepressants,
the third-largest class of drugs, experienced 17% sales
growth in 1999. With 26% growth and over $5 billion in
sales, antipsychotics was the fastest growing of the leading
therapy classes.
Detailed
reports of sales for the Top 20 Corporations,
Products,
Countries
and Therapy
Areas in 1998 and 1999 are available to buy online.
See
also: The global
pharmaceutical market report for 1998
For
full explanation of figures and collection methods see
Data Value and definitions
|